Glutamine and Insulin Sensitivity in Type I Diabetes

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

July 31, 2013

Conditions
Type I Diabetes Mellitus
Interventions
DIETARY_SUPPLEMENT

Glutamine

Participants will keep a diary of food intake and activity as well as wear an accelerometer (to measure overall movement) for 2-3 days prior to the admission. Subject will come to the Clinical Research Center for approximately 24 hours. They will receive a drink containing Glutamine (0.25 g/kg/dose). Afterwards they will have an afternoon exercise session consisting of 15-min bouts of exercise, interspersed with 5-min rest periods in between for a total of 75min. Blood glucose will be checked during rest intervals. They will be served a controlled dinner. Before bedtime another dose of the same drink will be given. Overnight blood glucose will be monitored closely. In the morning, another dose of the same drink will be given. Subjects will have two isotope infusions (non-radioactive) running concomitantly and a hyperinsulinemic-euglycemic clamp will be performed. Afterwards lunch will be served and subject discharged home.

DIETARY_SUPPLEMENT

Placebo

Participants will keep a diary of food intake and activity as well as wear an accelerometer (to measure overall movement) for 2-3 days prior to the admission. Subject will come to the Clinical Research Center for approximately 24 hours. They will receive a PLACEBO drink. Afterwards they will have an afternoon exercise session consisting of 15-min bouts of exercise, interspersed with 5-min rest periods in between for a total of 75min. Blood glucose will be checked during rest intervals. They will be served a controlled dinner. Before bedtime another dose of the same drink will be given. Overnight blood glucose will be monitored closely. In the morning, another dose of the same drink will be given. Subjects will have two isotope infusions (non-radioactive) running concomitantly and a hyperinsulinemic-euglycemic clamp will be performed. Afterwards lunch will be served and subject discharged home.

Trial Locations (1)

32207

Nemours Children's Clinic, Jacksonville

All Listed Sponsors
collaborator

Thrasher Research Fund

OTHER

lead

Nemours Children's Clinic

OTHER

NCT01467063 - Glutamine and Insulin Sensitivity in Type I Diabetes | Biotech Hunter | Biotech Hunter